| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $954K | -15.0% | -70.6% |
| SG&A Expense | $1.1M | +15.1% | -36.9% |
| Operating Income | -$2.1M | +0.9% | +58.6% |
| Net Income | -$2.0M | +0.3% | +58.5% |
| EPS (Basic) | -$0.19 | +5.0% | +61.2% |
| EPS (Diluted) | -$0.19 | +5.0% | +61.2% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $8.8M | +29.8% | -38.4% |
| Total Assets | $10.4M | +22.8% | -35.6% |
| Current Liabilities | $1.5M | -17.0% | -22.0% |
| Total Liabilities | $2.8M | -12.5% | -21.3% |
| Stockholders' Equity | $7.7M | +43.8% | -39.6% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.5M | — | — |
| Capital Expenditures | $12K | — | — |
| Investing Cash Flow | -$12K | — | — |
| Financing Cash Flow | $4.3M | — | — |
| Free Cash Flow | -$6.5M | — | — |